^
BIOMARKER:
RUNX1 mutation
i
Other names: RUNX1, RUNX Family Transcription Factor 1, Runt-Related Transcription Factor 1, Polyomavirus Enhancer-Binding Protein 2 Alpha B Subunit, SL3/AKV Core-Binding Factor Alpha B Subunit, SL3-3 Enhancer Factor 1 Alpha B Subunit, Runt Related Transcription Factor 1, Acute Myeloid Leukemia 1 Protein, Oncogene AML-1, PEBP2-Alpha B, PEA2-Alpha B, AMLCR1, CBFA2, AML1, Core-Binding Factor Subunit Alpha-2, AML1-EVI-1 Fusion Protein, Acute Myeloid Leukemia 1, Aml1 Oncogene, CBF-Alpha-2, AML1-EVI-1, PEBP2alpha
Entrez ID:
Related biomarkers:
RUNX1 mutation
AML
venetoclax
Sensitive
:
C2
EHA 2021 - 4d
RUNX1 mutation
CMML
venetoclax
Sensitive
:
C2
RUNX1 mutation
MDS
venetoclax
Sensitive
:
C2
RUNX1 mutation
MDS
pembrolizumab
Sensitive
:
C3
RUNX1 mutation
AML
venetoclax + RO5503781
Sensitive
:
C3
RUNX1 mutation
AML
LY3009120
Resistant
:
C3
RUNX1 mutation
AML
cytarabine/daunorubicin liposomal formulation
Resistant
:
C3
RUNX1 mutation
AML
cytarabine
Resistant
:
C3
RUNX1 mutation
MDS
azacitidine
Resistant
:
C3
RUNX1 mutation
AML
cytarabine + clofarabine
Sensitive
:
C3
RUNX1 mutation
AML
cytarabine + cladribine
Sensitive
:
C3
RUNX1 mutation
AML
decitabine + clofarabine
Sensitive
:
C3
RUNX1 mutation
AML
decitabine + cladribine
Sensitive
:
C3
RUNX1 mutation
AML
tagraxofusp
Sensitive
:
D
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our